Evidence map›Paper›PMID 38751432›Full record

ArticleFrontiers in immunology2024

Rewaida Abdel-Gaber, Ghada Alamari, Mohamed A Dkhil, Andreas Meryk, Esam M Al-Shaebi, Saleh Al-Quraishy

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Frontiers in immunology · 2025
    Article
  3. Antibacterial activity ofFrontiers in microbiology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rewaida Abdel-GaberDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Ghada AlamariDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mohamed A DkhilDepartment of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, Egypt.
Andreas MerykDepartment of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria.
Esam M Al-ShaebiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Saleh Al-QuraishyDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Recently, the use of botanicals as an alternative to coccidiostats has been an appealing approach for controlling coccidiosis. Therefore, this study was conducted to evaluate the potential role of aqueous methanolic extract (200 mg/kg) of Methods: A total of 25 male C57BL/6 mice were divided into five groups (I, II, III, IV, and V). On 1 Results: Treatment with extract and coccidiostat was continued for five consecutive days. While not reaching the efficacy level of the reference drug (amprolium), KLRE exhibited notable anticoccidial activity as assessed by key criteria, including oocyst suppression rate, total parasitic stages, and maintenance of nutrient homeostasis. The presence of phenolic and flavonoid compounds in KLRE is thought to be responsible for its positive effects. The Conclusion: Collectively,

Indexed as

AntioxidantsCD4-Positive T-LymphocytesCoccidiosisCoccidiostatsInterleukin-10Plant ExtractsAnimalsDisease Models, AnimalEimeriaMaleMiceMice, Inbred C57BLPlant RootsAntioxidantsCoccidiostatsIL10 protein, mouseInterleukin-10Plant ExtractsCD4 T cellsEimeria papillataIL-10Krameria lappaceaNFkB cellsoxidative damage

Identifiers

PMID38751432
PMCPMC11094240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.